- 1901. active transport
- [any ATP-driven cellular process for moving solutes or organelles; e.g., ATPase transmembrane pumps, pinocytosis and related membrane flux events, cytoskeletal rearrangements; contrast with PASSIVE TRANSPORT. ( CSP )] (UMLS (CSP) C0005529) =Physiologic Function ;
| - 1951. ActRelationshipConditional
- [Specifies under what circumstances (target Act) the source-Act may, must, must not or has occurred ( HL7V3.0 )] (UMLS (HL7) C1699170) =Functional Concept ;
=ActRelationshipType;
=has pre-condition;
has trigger;
has contra-indication;
has reason |
- 1902. Active Transporter Interaction
- [Active Transporter Interaction involves temporary non-covalent binding of a molecule through intermolecular physical forces of attraction with a protein that, after conformational change, moves a bound substrate across a cell membrane with (symport) or against (antiport) a concentration gradient resulting directly from the expenditure of energy. ( NCI )] (UMLS (NCI) C1373104) Active Transporter Interactions =Molecular Function =Receptor Interactions;
=Neurotransmitter Transporter Interactions;
ATP-Binding Cassette (ABC) Transporter Interactions;
Organic Anion Transporter Interactions;
Small Ion Transport Pump Interactions | - 1952. ActRelationshipCostTracking
- [Expresses values for describing the relationship relationship between an InvoiceElement or InvoiceElementGroup and a billable act. ( HL7V3.0 )] (UMLS (HL7) C1696132) =Qualitative Concept =ActRelationshipAccounting;
=has cost;
has charge |
- 1903. Active _ Consent has been granted
- (UMLS (HL7) C1548942) =Idea or Concept =Consent Status;
| - 1953. ActRelationshipExpectedSubset
- (UMLS (HL7) C1698962) =Idea or Concept =ActRelationshipSubset;
|
- 1904. Active/Inactive
- (UMLS (HL7) C1547601) =Idea or Concept =HL7 Vocabulary Version 2.5;
=Active Staff;
Inactive Staff;
| - 1954. ActRelationshipJoin
- (UMLS (HL7) C1553779) =Intellectual Product =CodeSystem;
=kill;
exclusive wait;
detached;
wait |
- 1905. Active/Valid
- (UMLS (HL7) C1549073) =Idea or Concept =Certificate Status;
| - 1955. ActRelationshipPastSubset
- (UMLS (HL7) C1698421) =Functional Concept ;
=ActRelationshipSubset;
|
- 1906. ActiveIngredientDrugEntityType
- [Any substance which, when combined with other ingredients, delivers all or part of the therapeutic benefit associated with a medication. ( HL7V3.0 )] (UMLS (HL7) C1698554) =Intellectual Product =ClinicalDrug;
| - 1956. ActRelationshipPosting
- [Expresses values for describing the relationship between a FinancialTransaction and an Account. ( HL7V3.0 )] (UMLS (HL7) C1697813) =Qualitative Concept =ActRelationshipAccounting;
=has debit;
has credit |
- 1907. Activin
- [produced in the pituitary, gonads, and other tissues; by acting locally, they stimulate pituitary FSH secretion and have diverse effects on cell differentiation and embryonic development. ( CSP )] (UMLS (NCI) C0050668) =Amino Acid, Peptide, or Protein; Hormone ;
=Peptide Hormone;
| - 1957. ActRelationshipSplit
- (UMLS (HL7) C1553780) =Intellectual Product =CodeSystem;
=exclusive try once;
exclusive wait;
inclusive try once;
inclusive wait |
- 1908. ActiVin
- (UMLS (NCI) C1135154) =Organic Chemical; Pharmacologic Substance ;
| - 1958. ActRelationshipSubset
- [Used to indicate that the target of the relationship will be a filtered subset of the total related set of targets. Used when there is a need to limit the number of components to the first, the last, the next, the total, the average or some other filtered or calculated subset. ( HL7V3.0 )] (UMLS (HL7) C1552606) =Intellectual Product =CodeSystem;
=most recent;
previous;
first known;
previous summary;
expected future;
expected next;
future summary;
minimum;
maximum;
summary;
ActRelationshipPastSubset;
expected last;
ActRelationshipExpectedSubset;
ParticipationSubset |
- 1909. Activin A
- [The inhibin beta A subunit joins the alpha subunit to form a pituitary FSH secretion inhibitor. Inhibin has been shown to regulate gonadal stromal cell proliferation negatively and to have tumor-suppressor activity. In addition, serum levels of inhibin have been shown to reflect the size of granulosa-cell tumors and can therefore be used as a marker for primary as well as recurrent disease. Because expression in gonadal and various extragonadal tissues may vary severalfold in a tissue-specific fashion, it is proposed that inhibin may be both a growth/differentiation factor and a hormone. Furthermore, the beta A subunit forms a homodimer, activin A, and also joins with a beta B subunit to form a heterodimer, activin AB, both of which stimulate FSH secretion. (from LocusLink) ( NCI )] (UMLS (NCI) C0532964) =Amino Acid, Peptide, or Protein; Biologically Active Substance
| - 1959. ActRelationshipType
- [The source is an excerpt from the target. ( HL7V3.0 )] (UMLS (HL7) C1553725) =Intellectual Product =CodeSystem;
=has component;
Retired Code;
has outcome;
has pertinent information;
is sequel;
Retired Code;
ActRelationshipConditional;
ActClassTemporallyPertains |
- 1910. Activin A Receptor Type II-Like 1
- [Activin A receptor, type II-like 1 (also called activin receptor-like kinase 1) is a type I cell-surface receptor for the TGF-beta superfamily of ligands. It shares with other type I receptors a high degree of similarity in serine-threonine kinase subdomains, a glycine- and serine-rich region (called the GS domain) preceding the kinase domain, and a short C-terminal tail. The ACVRL1 gene encodes a protein that shares similar domain structures with 3 other closely related ALK proteins (ALK2, ALK3, and ALK4) that together form a subfamily of receptor serine/threonine kinases. ACVRL1 is most highly expressed in human placenta and lung. ACVRL1 deficiency causes hemorrhagic telangiectasia type 2 (HHT2) also known as Rendu-Osler-Weber syndrome 2 (ORW2). ( NCI )] (UMLS (NCI) C0380146) =Amino Acid, Peptide, or Protein; Enzyme
| - 1960. ActSite
- [An anatomical location on an organism which can be the focus of an act. ( HL7V3.0 )] (UMLS (HL7) C1553743) =Intellectual Product =CodeSystem;
=AnimalActSite;
HumanActSite;
|
- 1911. Activin A Receptor Type II-Like Kinase 53kDa
- [Expressed in all tissues (most in placenta) by human TGFBR1 Gene (TGFBR Ser/Thr Family), 503-aa 53-kDa (56-kDa precursor) Transforming Growth Factor Beta Receptor I is a type I transmembrane protein receptor for multifunctional cytokine TGFB1 containing a signal peptide, an extracellular Cys-rich region with an N-glycosylation site, a transmembrane region, and a cytoplasmic protein Ser/Thr kinase domain that mediates induction of cell-matrix adhesion genes and regulates cell cycle progression. TGF-beta binds either TGFBR1 or transmembrane Ser/Thr TGF-Beta II receptor, which form an active heterodimeric complex. TGFB stimulation leads to phosphorylation and activation of SMAD2 and SMAD3, which, complexed with SMAD4, accumulate in the nucleus and regulate transcription of target genes. Continuous SMAD nucleocytoplasmic shuttling during TGFB signaling monitors receptor activity. (NCI) ( NCI )] (UMLS (NCI) C0292688) =Amino Acid, Peptide, or Protein; Enzyme
| - 1961. ActSpecimenTreatmentCode
- [Set of codes related to specimen treatments ( HL7V3.0 )] (UMLS (HL7) C1699120) =Intellectual Product ;
=HL7DefinedActCodes;
=LDL Precipitation;
Recalcification;
Defibrination;
Acidification;
Alkalization;
Filtration;
Neutralization;
Ultrafiltration |
- 1912. Activin A Receptor, Type I
- [Activins are dimeric growth and differentiation factors that belong to the TGF-beta superfamily of signaling proteins. Activins signal through a heteromeric complex of receptor serine kinases that include at least two type I (I and IB) and two type II (II and IIB) receptors. These receptors are all transmembrane proteins composed of a ligand-binding extracellular domain with cysteine-rich region, a transmembrane domain, and a cytoplasmic domain with predicted serine/threonine specificity. Type I receptors are essential for signaling and type II receptors are required for binding ligands and for expression of type I receptors. Type I and II receptors form a stable complex after ligand binding, resulting in phosphorylation of type I receptors by type II receptors. Encoded by human ACVR1 Gene, Activin A Receptor Type I signals a particular transcriptional response in concert with activin type II receptors. (LocusLink) ( NCI )] (UMLS (NCI) C1447968) Activin A Receptor, Type II-Like Kinase 2;
ACVR1;
EC 2.7.1.37;
Hydroxyalkyl-Protein Kinase =Amino Acid, Peptide, or Protein; Enzyme; Receptor | - 1962. ActSpecObsArtBldCode
- [Describes the artificial blood identifier that is associated with the specimen. ( HL7V3.0 )] (UMLS (HL7) C1553192) =Intellectual Product =ActSpecObsCode;
|
- 1913. Activin A Receptor, Type IB Gene
- [This gene plays a role in the transforming growth factor-beta signal transduction pathway. The gene also plays a role in the regulation of cellular growth, differentiation and signal transduction. ( NCI )] (UMLS (NCI) C1332011) ACVR1B;
ACVR1B Gene;
=Gene or Genome ;
| - 1963. ActSpecObsCode
- [Identifies the type of observation that is made about a specimen that may affect its processing, analysis or further result interpretation ( HL7V3.0 )] (UMLS (HL7) C1697985) =Intellectual Product =HL7DefinedActCodes;
=ActSpecObsDilutionCode;
ActSpecObsVolumeCode;
ActSpecObsInterferenceCode;
ActSpecObsArtBldCode;
ActSpecObsEvntfctsCode;
|
- 1914. Activin A Receptor, Type II-Like Kinase 1 Gene
- [This gene is involved in the mediation of cell-surface receptor interactions for the TGF-beta superfamily of ligands. ( NCI )] (UMLS (NCI) C1366767) ACVRL1;
ACVRL1 Gene =Gene or Genome ;
| - 1964. ActSpecObsDilutionCode
- [An observation that reports the dilution of a sample. ( HL7V3.0 )] (UMLS (HL7) C1553185) =Intellectual Product =ActSpecObsCode;
=Auto-High Dilution;
Auto-Low Dilution;
Rerun Dilution;
Pre-Dilution |
- 1915. Activin A Receptor, Type II-Like Kinase 4
- [Expressed in kidney, pancreas, brain, lung, and liver and encoded by human ACVR1B Gene (TGFBR Family), 505-aa 57-kD Activin A Type IB Receptor (isoforms A, B, and C) is a type I membrane protein with intracellular Ser/Thr kinase domain. Isoform A contains a complete kinase domain; B and C have truncated kinase domains and distinct C-termini. Activins signal through a transmembrane heteromeric complex of type I and type II receptors that all contain a ligand-binding extracellular domain with a cysteine-rich region. Type I receptors are essential for signaling and type II receptors are required for binding ligand. Type I and II receptors form a stable complex after ligand binding, resulting in phosphorylation of type I receptors by type II receptors. ( NCI )] (UMLS (NCI) C0663443) =Amino Acid, Peptide, or Protein; Enzyme; Receptor
| - 1965. ActSpecObsEvntfctsCode
- [Domain provides codes that qualify the ActLabObsEnvfctsCode domain. (Environmental Factors) ( HL7V3.0 )] (UMLS (HL7) C1553193) =Intellectual Product =ActSpecObsCode;
|
- 1916. Activin A Receptor, Type IIB Gene
- [This gene plays a role in the transforming growth factor-beta signal transduction pathway and is essential for ligand binding and kinase activity. ( NCI )] (UMLS (NCI) C1332013) ACVR2B;
ACVR2B Gene;
=Gene or Genome ;
| - 1966. ActSpecObsInterferenceCode
- [An observation that relates to factors that may potentially cause interference with the observation ( HL7V3.0 )] (UMLS (HL7) C1553187) =Intellectual Product =ActSpecObsCode;
=Hemolysis;
Lipemia;
Icterus;
Fibrin |
- 1917. Activin A Type II Receptor
- [Activins are dimeric growth and differentiation factors which belong to the transforming growth factor-beta (TGF-beta) superfamily of structurally related signaling proteins. Activins signal through a heteromeric complex of receptor serine kinases which include at least two type I (I and IB) and two type II (II and IIB) receptors. Activin A type II receptor, encoded by the ACVR2 gene, is a receptor for activin A, activin B, and activin C and constitutively active kinase. Type I receptors are essential for transmembrane signaling and type II receptors are required for binding ligands and for expression of type I receptors. Type I and II receptors form a stable complex after ligand binding, resulting in phosphorylation of type I receptors by type II receptors. (From LocusLink, OMIM and NCI) ( NCI )] (UMLS (NCI) C0754834) ACTR-II;
ACTRIIA;
ACVR2 =Amino Acid, Peptide, or Protein; Enzyme; Receptor | - 1967. ActSpecObsVolumeCode
- [An observation that reports the volume of a sample. ( HL7V3.0 )] (UMLS (HL7) C1553186) =Intellectual Product =ActSpecObsCode;
=Current Volume;
Available Volume;
Initial Volume;
Consumption Volume |
- 1918. Activin A Type IIB Receptor
- [Activins are dimeric growth and differentiation factors that belong to the TGF-beta superfamily of signaling proteins. Activins signal through a heteromeric complex of receptor serine kinases which include at least two type I (I and IB) and two type II (II and IIB) receptors. Type I receptors are essential for signaling and type II receptors are required for binding ligands and for expression of type I receptors. Type I and II receptors form a stable complex after ligand binding, resulting in phosphorylation of type I receptors by type II receptors. Activin A type IIB receptor, encoded by the ACVR2 gene and a receptor for activin A, activin B, and activin C, displays a 3- to 4-fold higher affinity for the ligand than activin A type II receptor. (From LocusLink, Swiss_Prot) ( NCI )] (UMLS (NCI) C0246504) =Amino Acid, Peptide, or Protein; Enzyme; Receptor
| - 1968. ActStatus
- [Contains the names (codes) for each of the states in the state-machine of the RIM Act class. ( HL7V3.0 )] (UMLS (HL7) C1553788) =Intellectual Product =CodeSystem;
=obsolete;
nullified;
normal;
|
- 1919. Activin AB Beta
- [The inhibin beta B subunit joins the alpha subunit to form a pituitary FSH secretion inhibitor. Inhibin has been shown to regulate gonadal stromal cell proliferation negatively and to have tumor-suppressor activity. In addition, serum levels of inhibin have been shown to reflect the size of granulosa-cell tumors and can therefore be used as a marker for primary as well as recurrent disease. Because expression in gonadal and various extragonadal tissues may vary severalfold in a tissue-specific fashion, it is proposed that inhibin may be both a growth/differentiation factor and a hormone. Furthermore, the beta B subunit forms a homodimer, activin B, and also joins with the beta A subunit to form a heterodimer, activin AB, both of which stimulate FSH secretion. (LocusLink) ( NCI )] (UMLS (NCI) C1447906) Beta-2 Inhibin;
INHBB;
Inhibin Beta B;
Inhibin Beta-2 =Amino Acid, Peptide, or Protein; Biologically Active Substance ;
| - 1969. ActSubstanceAdministrationCode
- [Describes the type of substance administration being performed. ( HL7V3.0 )] (UMLS (HL7) C1699064) =Intellectual Product =HL7DefinedActCodes;
=chemotherapy;
|
- 1920. activin binding protein
- [activin-binding protein which inhibits the action of activin, and thereby inhibits the release of follicle stimulating hormone. ( CSP )] (UMLS (CSP) C0060623) =Amino Acid, Peptide, or Protein; Biologically Active Substance =Folliculostatin;
binding protein | - 1970. ActSubstanceAdminSubstitutionCode
- (UMLS (HL7) C1700835) =Intellectual Product ;
=SubstanceAdminSubstitution;
=none;
generic;
formulary;
|
- 1921. activin receptor
- [Receptors for ACTIVINS are membrane protein kinases belonging to the family of PROTEIN-SERINE-THREONINE KINASES, thus also named activin receptor-like kinases (ALK's). Activin receptors also bind TRANSFORMING GROWTH FACTOR BETA. As those transmembrane receptors of the TGF-beta superfamily (RECEPTORS, TRANSFORMING GROWTH FACTOR BETA), ALK's consist of two different but related protein kinases, Type I and Type II. Activins initiate cellular signal transduction by first binding to the type II receptors (ACTIVIN RECEPTORS, TYPE II ) which then recruit and phosphorylate the type I receptors (ACTIVIN RECEPTORS, TYPE I ) with subsequent activation of the type I kinase activity. ( MSH )] (UMLS (CSP) C0101389) =Amino Acid, Peptide, or Protein; Enzyme; Receptor
| - 1971. ActSuppliedItemDetectedIssueCode
- [Identifies types of detected issues regarding the administration or supply of an item to a patient. ( HL7V3.0 )] (UMLS (HL7) C1697986) =Intellectual Product =ActDetectedIssueCode;
=AdministrationDetectedIssueCode;
SupplyDetectedIssueCode |
- 1922. Activity
- [An action taken in pursuit of an objective; the state of being active. ( NCI )] (UMLS (NCI) C0441655) =Activity
| - 1972. ActSupplyFulfillmentRefusalReason
- [ Indicates why a fulfiller refused to fulfill a supply order, and considered it important to notify other providers of their decision. E.g. "Suspect fraud", "Possible abuse", "Contraindicated".(used when capturing 'refusal to fill' annotations) ( HL7V3.0 )] (UMLS (HL7) C1699090) =Idea or Concept =ActReason;
|
- 1923. activity of daily living
- [physical, mental, or social ability to carry on the normal activities of life. ( CSP )] (UMLS (CSP) C0001288) =Daily or Recreational Activity ;
| - 1973. ActTherapyDurationWorkingListCode
- [ Codes used to identify different types of 'duration-based' working lists. Examples include "Continuous/Chronic", "Short-Term" and "As-Needed". ( HL7V3.0 )] (UMLS (HL7) C1699594) =Intellectual Product ;
=ActListCode;
|
- 1924. ActListCode
- [Provides codes associated with ActClass value of LIST (working list) ( HL7V3.0 )] (UMLS (HL7) C1697936) =Intellectual Product =HL7DefinedActCodes;
=medication list;
ActObservationList;
ActTherapyDurationWorkingListCode;
| - 1974. ActTransportationModeCode
- [ Characterizes how a transportation act was or will be carried out. Examples: Via private transport, via public transit, via courier. ( HL7V3.0 )] (UMLS (HL7) C1698185) =Intellectual Product ;
=ActCode;
|
- 1925. ActMedicalServiceCode
- [General category of medical service provided to the patient during their encounter. ( HL7V3.0 )] (UMLS (HL7) C1698550) =Intellectual Product =ActEncounterCode;
=Physical Rehab;
Obstetrics;
General;
Pharmaceutical;
Surgical;
Palliative;
Chronic;
Drug Rehab;
Oncology;
Alternative Level of Care;
Pediatrics;
Cardiology;
Dental;
Medical;
Psychiatric | - 1975. Actual
- [Existing in fact; real. ( NCI )] (UMLS (NCI) C0237400) =Qualitative Concept ;
|
- 1926. ActMonitoringProtocolCode
- [Identifies types of monitoring programs ( HL7V3.0 )] (UMLS (HL7) C1697937) =Intellectual Product =HL7DefinedActCodes;
=Controlled Substance;
| - 1976. Actual count
- (UMLS (HL7) C1548590) =Idea or Concept =Quantity method;
|
- 1927. ActMood
- (UMLS (HL7) C1553724) =Intellectual Product =CodeSystem;
=recommendation;
risk;
expectancy;
permission;
permission request;
ActMoodCompletionTrack;
ActMoodPredicate;
| - 1977. Actual product involved in incident was evaluated
- (UMLS (HL7) C1546981) =Idea or Concept =Product source;
|
- 1928. ActMoodCompletionTrack
- [These are moods describing activities as they progress in the business cycle, from defined, through planned and ordered to completed. ( HL7V3.0 )] (UMLS (HL7) C1699124) =Functional Concept ;
=ActMood;
=definition;
intent;
event (occurrence);
| - 1978. ActUncertainty
- (UMLS (HL7) C1553744) =Intellectual Product =CodeSystem;
=stated with no assertion of uncertainty;
stated with uncertainty;
|
- 1929. ActMoodPredicate
- [Any of the above service moods (e.g., event, intent, or goal) can be turned into a predicate used as a criterion to express conditionals (or queries.) However, currently we allow only criteria on service events. ( HL7V3.0 )] (UMLS (HL7) C1699125) =Functional Concept ;
=ActMood;
=event criterion;
option;
Goal;
| - 1979. ACU BRNCHLTS D/T OTH ORG
- [ ] (UMLS (ICD9CM) C0375319) =Disease or Syndrome ;
|
- 1930. ActNoImmunizationReason
- [ A coded description of the reason for why a patient did not receive a scheduled immunization.(important for public health strategy ( HL7V3.0 )] (UMLS (HL7) C1699089) =Intellectual Product =ActReason;
| - 1980. ACU BRONCHOLITIS D/T RSV
- [ ] (UMLS (ICD9CM) C0348799) =Disease or Syndrome
|
- 1931. actobindin
- [ ] (UMLS (CSP) C0050669) =Amino Acid, Peptide, or Protein; Biologically Active Substance ;
| - 1981. acupressure
- [The application of pressure or localized massage to specific sites on the body to control symptoms such as pain or nausea. Also used to stop bleeding. ( NCI )] (UMLS (NCI) C0282614) =Therapeutic or Preventive Procedure ;
|
- 1932. ActObservationList
- (UMLS (HL7) C1699294) =Intellectual Product ;
=ActListCode;
=condition list;
goal list;
care plan | - 1982. Acupuncture
- [Treatment of certain painful conditions by passing long thin needles through the skin to specific points, resulting in regional anesthesia. The free ends of the needles are twirled or in some cases used to conduct a weak electric current. Anesthesia sufficient to permit abdominal, thoracic, and head and neck surgery has been produced by the use of acupuncture alone. The patient is fully conscious during the surgery. Acupuncture has been known in the Far East for centuries but received little attention in Western cultures until the early 1970s. (Taber's) ( NCI )] (UMLS (NCI) C0394664) =Therapeutic or Preventive Procedure
|
- 1933. actomyosin
- [A protein complex of actin and MYOSINS occurring in muscle. It is the essential contractile substance of muscle. ( MSH )] (UMLS (CSP) C0001291) =Amino Acid, Peptide, or Protein; Biologically Active Substance
| - 1983. Acupuncture for anesthesia
- [Use of ACUPUNCTURE to block the afferent nerve impulses from reaching the brain to reduce the sensation of pain for surgery. ( MSH )] (UMLS (ICD9CM) C0001301) =Therapeutic or Preventive Procedure ;
|
- 1934. actomyosin ATPase
- [ ] (UMLS (CSP) C0001478) =Amino Acid, Peptide, or Protein; Enzyme ;
| - 1984. acupuncture/acupressure
- [traditional Chinese methods of acupuncture therapy for treating disease by inserting needles along specific pathways or meridians; acupressure uses the same pressure points as acupuncture, but is a type of massage in which finger pressure on specific body sites is used to promote healing, relieve fatigue, etc. ( CSP )] (UMLS (CSP) C0596036) =Therapeutic or Preventive Procedure ;
=alternative medicine;
Therapeutic Interventions |
- 1935. Actonel
- (UMLS (NCI) C0718248) Actonel brand of risedronate sodium =Organic Chemical; Pharmacologic Substance ;
| - 1985. Acupuncturist
- [An acupuncturist is a person who performs ancient therapy for alleviation of pain, anesthesia and treatment of some diseases. Acupuncturists use long, fine needles inserted into specific points in order to treat painful conditions or produce anesthesia. ( HL7V3.0 )] (UMLS (HL7) C1556023) =Intellectual Product =Other Service Providers;
|
- 1936. actophorin
- [ ] (UMLS (CSP) C0050671) =Amino Acid, Peptide, or Protein; Biologically Active Substance
| - 1986. Acute
- (UMLS (HL7) C1547229) =Intellectual Product =Triage Code;
◊ (UMLS (HL7) C1547295) Intellectual Product Admission Level of Care Code; |
- 1937. ActOrderCode
- [The type of order that was fulfilled by the clinical service ( HL7V3.0 )] (UMLS (HL7) C1698551) =Intellectual Product =HL7DefinedActCodes;
| - 1987. Acute
- [Having an abrupt onset of symptoms and a short course; not chronic. ( NCI )] (UMLS (NCI) C0205178) =Temporal Concept
|
- 1938. ActPatientTransportationModeCode
- [ Definition: Characterizes how a patient was or will be transported to the site of a patient encounter. Examples: Via ambulance, via public transit, on foot. ( HL7V3.0 )] (UMLS (HL7) C1699600) =Intellectual Product ;
=ActCode;
=ambulance transport;
private transport;
public transport;
law enforcement transport;
pedestrian transport | - 1988. ACUTE & CHRONC RESP FAIL
- [ ] (UMLS (ICD9CM) C0264491) =Disease or Syndrome
|
- 1939. ActPaymentCode
- [Code identifying the method or the movement of payment instructions. Codes are drawn from X12 data element 591 (PaymentMethodCode) ( HL7V3.0 )] (UMLS (HL7) C1699118) =Intellectual Product ;
=HL7DefinedActCodes;
=Automated Clearing House;
Cheque;
Direct Deposit;
Non-Payment Data | - 1989. Acute (transverse) myelitis
- [ ] (UMLS (ICD9CM) C0270627) =Disease or Syndrome
|
- 1940. ActPharmacySupplyType
- [Identifies types of dispensing events ( HL7V3.0 )] (UMLS (HL7) C1699636) =Intellectual Product ;
=HL7DefinedActCodes;
=First Fill;
Refill;
Manufacturer Sample;
Emergency Supply;
Floor stock | - 1990. Acute (transverse) myelitis in conditions classified elsewhere
- [ ] (UMLS (ICD9CM) C1719403) ACUTE MYELITIS OTH COND =Disease or Syndrome ;
|
- 1941. ActPriority
- (UMLS (HL7) C1553836) =Intellectual Product =CodeSystem;
=emergency;
Immediate;
Routine;
use as directed;
ASAP;
preop;
callback for scheduling;
timing critical;
as needed;
callback results;
Rush reporting;
elective;
urgent;
| - 1991. Acute Acalculous Cholecystitis
- (UMLS (NCI) C0267842) =Disease or Syndrome
|
- 1942. ActPrivilegeCategorization
- [An Act which characterizes a Privilege can have additional observations to provide a finer definition of the requested or conferred privilege. This domain describes the categories under which this additional information is classified. ( HL7V3.0 )] (UMLS (HL7) C1699596) =Classification ;
=ActCode;
| - 1992. Acute Adult T-Cell Lymphoma/Leukemia
- [The most common variant of adult T-cell lymphoma/leukemia. It is characterized by systemic disease with a leukemic phase, generalized lymphadenopathy, and skin lesions. Hypercalcemia is commonly seen. — 2004 ( NCI )] (UMLS (NCI) C1332146) =Neoplastic Process ;
|
- 1943. ActPrivilegeCategorizationType
- [This domain includes observations used to characterize a privilege, under which this additional information is classified. Examples:A privilege to prescribe drugs has a RESTRICTION that excludes prescribing narcotics; a surgical procedure privilege has a PRE-CONDITION that it requires prior Board approval. ( HL7V3.0 )] (UMLS (HL7) C1699131) =Intellectual Product ;
=ActCode;
| - 1993. Acute alcohol abuse
- (UMLS (ICPC) C0497318) (Acute alcohol abuse; ALKOLAREN ABUSU ZORROTZA; Akut alkoholmisbrug; Acuut alcohol misbruik; AKUUTTI ALKOHOLIN VAARINKAYTTO; Intoxication aigue alcool; akute Alkoholintoxikation; (108); acut alkohol abusus; Abuso acuto di alcool; AKUTT ALKOHOLPROBLEM; Abuso agudo de alcool; Abuso del alcohol agudo; AKUT ALKOHOLMISSBRUK) =Mental or Behavioral Dysfunction =Symptoms and Complaints Component; PSYCHOLOGICAL
|
- 1944. ActProcedureCode
- [An identifying code for healthcare interventions/procedures. ( HL7V3.0 )] (UMLS (HL7) C1698584) =Intellectual Product ;
=HL7DefinedActCodes;
| - 1994. Acute alcoholic intoxication
- [ ] (UMLS (ICD9CM) C0394996) =Mental or Behavioral Dysfunction
|
- 1945. ActProductAcquisitionCode
- [The method that a product is obtained for use by the subject of the supply act (e.g. patient). Product examples are consumable or durable goods. ( HL7V3.0 )] (UMLS (HL7) C1699119) =Intellectual Product ;
=HL7DefinedActCodes;
=Transfer;
Loan | - 1995. Acute and subacute endocarditis
- [ ] (UMLS (ICD9CM) C0155683) =Disease or Syndrome
|
- 1946. ACTR
- [NCOA3 is a nuclear receptor coactivator that directly binds nuclear receptors and stimulates the transcriptional activities in hormone-dependent fashion. NCOA3 recruits 2 other nuclear factors, CBP and PCAF, and thus plays a central role in creating a multisubunit coactivator complex. (LocusLink) ( NCI )] (UMLS (NCI) C0663204) =Amino Acid, Peptide, or Protein; Biologically Active Substance ;
| - 1996. Acute and subacute iridocyclitis
- [ ] (UMLS (ICD9CM) C0154908) =Disease or Syndrome
|
- 1947. ActReason
- (UMLS (HL7) C1553844) =Intellectual Product =CodeSystem;
=scheduled;
non-protocol;
Retired Code;
Retired Code;
Retired Code;
Retired Code;
Retired Code;
Retired Code;
Retired Code;
termination;
ReasonForNotEvaluatingDevice;
ActAccommodationReason;
ActAdjudicationReason;
ActBillableClinicalServiceReason;
ActIneligibilityReason;
TransferActReason;
retest;
per protocol;
ControlActReason;
ControlActReasonConditionNullify;
SubstanceAdminSubstitutionReason;
ActNoImmunizationReason;
ActSupplyFulfillmentRefusalReason;
SubstanceAdminSubstitutionNotAllowedReason;
ReferralReasonCode;
ActInvoiceCancelReason;
EligibilityActReasonCode;
NonPerformanceReasonCode;
SchedulingActReason;
unscheduled;
per definition | - 1997. Acute and subacute necrosis of liver
- (UMLS (ICD9CM) C0001308) =Disease or Syndrome ;
|
- 1948. ActRegistryCode
- [This is the domain of registry types. Examples include Master Patient Registry, Staff Registry, Employee Registry, Tumor Registry. ( HL7V3.0 )] (UMLS (HL7) C1699637) =Intellectual Product ;
=HL7DefinedActCodes;
| - 1998. Acute and unspecified inflammation of lacrimal passages
- [ ] (UMLS (ICD9CM) C0339129) =Disease or Syndrome ;
|
- 1949. ActRelationshipAccounting
- [Codes that describe the relationship between an Act and a financial instrument such as a financial transaction, account or invoice element. ( HL7V3.0 )] (UMLS (HL7) C1698639) =Qualitative Concept =has pertinent information;
=ActRelationshipCostTracking;
ActRelationshipPosting;
ActRelationshipCostTracking;
ActRelationshipPosting;
| - 1999. ACUTE ANGL-CLOS GLAUCOMA
- [ ] (UMLS (ICD9CM) C0154946) =Disease or Syndrome ;
|
- 1950. ActRelationshipCheckpoint
- (UMLS (HL7) C1553722) =Intellectual Product =CodeSystem;
=entry;
through;
exit;
end;
beginning;
| - 2000. Acute appendicitis
- [Acute inflammation of the vermiform appendix. ( NCI )] (UMLS (ICD9CM) C0085693) =Disease or Syndrome
|
home 
Armenian-English 
top